SPARQL
Query
Update
Search
Quick
Advanced
Co-occurrence
RelFinder
About
Sources
Admin
System Info
Repository Management
Search Configuration
Sources
18805838
Source:
http://linkedlifedata.com/resource/pubmed/id/18805838
Search
Subject
(
52
)
Predicate
Object
All
Download in:
JSON
RDF
N3/Turtle
N-Triples
Switch to
Custom View
Named Graph
All
UniProt
NCBIGene
DrugBank
ClinicalTrials
UMLS
PubMed
Mappings
MentionedEntities
Language
All
English
Español
Português
Français
Deutsch
Русский
日本語
Български
Inference
Explicit and implicit
Explicit only
Implicit only
Statements in which the resource exists as a subject.
Predicate
Object
rdf:type
pubmed:Citation
lifeskim:mentions
umls-concept:C0026769
,
umls-concept:C0030705
,
umls-concept:C0086860
,
umls-concept:C0332281
,
umls-concept:C0597198
,
umls-concept:C1412468
,
umls-concept:C1516691
,
umls-concept:C1882417
pubmed:issue
2
pubmed:dateCreated
2009-2-2
pubmed:abstractText
Elevated ApoA1 levels have been associated with decreased dementia risk. The A-allele of the APOA1 -75G/A promoter polymorphism has been associated with elevated ApoA1 levels.
pubmed:language
eng
pubmed:journal
http://linkedlifedata.com/resource/pubmed/journal/9509185
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/APOA1 protein, human
,
http://linkedlifedata.com/resource/pubmed/chemical/Apolipoprotein A-I
pubmed:status
MEDLINE
pubmed:month
Feb
pubmed:issn
1352-4585
pubmed:author
pubmed-author:GiogkarakiEE
,
pubmed-author:KaradimaGG
,
pubmed-author:KoutsisGG
,
pubmed-author:PanakEE
,
pubmed-author:SfagosCC
,
pubmed-author:VassilopoulosDD
pubmed:issnType
Print
pubmed:volume
15
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
174-9
pubmed:meshHeading
pubmed-meshheading:18805838-Adult
,
pubmed-meshheading:18805838-Apolipoprotein A-I
,
pubmed-meshheading:18805838-Cognition
,
pubmed-meshheading:18805838-Cognition Disorders
,
pubmed-meshheading:18805838-Female
,
pubmed-meshheading:18805838-Genetic Predisposition to Disease
,
pubmed-meshheading:18805838-Genotype
,
pubmed-meshheading:18805838-Greece
,
pubmed-meshheading:18805838-Humans
,
pubmed-meshheading:18805838-Male
,
pubmed-meshheading:18805838-Middle Aged
,
pubmed-meshheading:18805838-Multiple Sclerosis
,
pubmed-meshheading:18805838-Neuropsychological Tests
,
pubmed-meshheading:18805838-Polymorphism, Genetic
,
pubmed-meshheading:18805838-Promoter Regions, Genetic
,
pubmed-meshheading:18805838-Risk Factors
,
pubmed-meshheading:18805838-Verbal Learning
pubmed:year
2009
pubmed:articleTitle
An APOA1 promoter polymorphism is associated with cognitive performance in patients with multiple sclerosis.
pubmed:affiliation
Department of Neurology, University of Athens, Aeginition Hospital, Athens, Greece. gkoutsi2@otenet.gr
pubmed:publicationType
Journal Article